Europe Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Europe Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR746
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Nasal sprays are the devices that help in the delivery of the drug through nose in the nasal cavity to treat allergy and other problems related to brain inflammation, diabetes, dental problems, central nervous system. Allergy is a condition in which immune system of the body reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients. There are different types of nasal spray available in the market such as decongestion nasal spray, saline nasal spray and steroid nasal spray. Decongestants are used to treat nasal congestion which provides short-term relief for a blocked or stuffy nose. Decongestion nasal spray comprises of drugs which shrinks the swollen membranes and open ups the airways of the nasal part which makes the breathing process easier.

Europe nasal spray market is expected to CAGR with 6.1% in the forecast period 2018 to 2025. The new market report contains data for the historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation:

By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Others), Container Design (Pressurized Canisters, Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose, Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, Others), End User (Home Care Settings, Hospitals, Clinics, Community Health Care), Country (Europe)

Major growing sectors under the market segmentation are as follows:

In product type, decongestion nasal spray segment is expected to dominate the global nasal spray market due to the rising problems associated with the decongestion of conditions such as colds & flu, hay fever, allergic reactions and sinusitis are helping the segment to grow in the forecast period of 2018 to 2025.

In therapeutic class, antihistamine segment is expected to dominate the market due to rising antihistamine usage amongst the population for different diseases such as congestion, runny nose, sneezing, itching, nasal swelling and different products availability by the companies is expected to dominate the market, whereas nasal steroids are available for both prescription and over the counter usage, and fast effective results are the major growth factors of the market.

In container design, pump bottles segment is expected to dominate the market due to the user friendly and wide offering of the over the counter products by the companies and it is expected to fuel the growth of pump bottles market in the forecast period. However, new advancement associated with the pressurized canisters.

In prescription segment, prescription based segment is expected to dominate the market due to the rising chances of seasonal associated nasal problems and also for the various diseases such as pulmonary, dental anesthesia and others which leads the growth of prescription based segment is expected to fuel in the forecast period of 2018 to 2025.

In application segment, nasal congestion segment is expected to dominate the market due to the rising cases of nasal congestion diseases such as runny nose, sinus pain, mucus buildup and also availability of the over the counter products, nasal congestion segment is expected to dominate market. However, allergic and non-allergic rhinitis is the fastest growing segment among all because of the rising problems amongst population such as antihistamines, nasal corticosteroids, hay fever and other, also seasonal imbalance is one of the reasons in raising the allergic and non-allergic rhinitis segment to grow in the forecast period with the highest CAGR.

The key market players for Europe nasal spray market are listed below:

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 20

1.1 OBJECTIVES OF THE STUDY 20

1.2 MARKET DEFINITION 20

1.3 OVERVIEW OF NASAL SPRAY MARKET 21

1.4 CURRENCY AND PRICING 22

1.5 LIMITATION 22

1.6 MARKETS COVERED 22

2 MARKET SEGMENTATION 25

2.1 MARKETS COVERED 25

2.2 GEOGRAPHIC SCOPE 26

2.3 YEARS CONSIDERED FOR THE STUDY 27

2.4 CURRENCY AND PRICING 27

2.5 RESEARCH METHODOLOGY 28

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31

2.7 SECONDARY SOURCES 32

2.8 ASSUMPTIONS 32

3 MARKET OVERVIEW 33

3.1 DRIVERS 35

3.1.1 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY 35

3.1.2 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY 36

3.1.3 INCREASE IN INFECTION & ALLERGIC CASES 37

3.2 RESTRAINTS 37

3.2.1 PRODUCT RECALLS 37

3.3 OPPORTUNITIES 38

3.3.1 NEW RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY 38

3.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS 38

3.4 CHALLENGES 39

3.4.1 REGULATORY HURDLES 39

4 EXECUTIVE SUMMARY 40

5 PREMIUM INSIGHTS 43

?

6 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE 45

6.1 OVERVIEW 46

6.2 DECONGESTION NASAL SPRAY 48

6.3 SALT WATER SOLUTION/ SALINE NASAL SPRAY 49

6.4 STEROID NASAL SPRAY 51

6.5 OTHERS 52

7 EUROPE N ASAL SPRAY MARKET, BY CONTAINER DESIGN 53

7.1 OVERVIEW 54

7.2 PRESSURIZED CANISTERS 56

7.3 PUMP BOTTLES 57

8 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM 58

8.1 OVERVIEW 59

8.2 UNIT/SINGLE DOSE 61

8.3 BI DOSE 63

8.4 MULTI DOSE 64

9 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS 66

9.1 OVERVIEW 67

9.2 ANTIHISTAMINE 69

9.3 NASAL STEROIDS 71

9.4 MAST CELL INHIBITOR 72

9.5 ANTICHOLINERGIC 73

10 EUROPE NASAL SPRAY MARKET, BY APPLICATION 74

10.1 OVERVIEW 75

10.2 ALLERGIC AND NON-ALLERGIC RHINITIS 77

10.3 NASAL CONGESTION 79

10.4 CENTRAL NERVOUS SYSTEM DISORDERS 80

10.5 VACCINATION 81

10.6 OTHERS 82

11 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION MODE 83

11.1 OVERVIEW 84

11.2 PRESCRIPTION BASED 86

11.3 OVER THE COUNTER 87

?

12 EUROPE NASAL SPRAY MARKET, BY END USER 89

12.1 OVERVIEW 90

12.2 HOSPITALS 92

12.3 CLINICS 93

12.4 HOME CARE SETTINGS 94

12.5 COMMUNITY HEALTH CARE 95

13 EUROPE NASAL SPRAY MARKET, BY GEOGRAPHY 96

13.1 EUROPE 96

13.1.1 STRICT GOVERNMENT REGULATIONS 96

13.1.2 GERMANY 105

13.1.3 U.K. 109

13.1.4 FRANCE 113

13.1.5 ITALY 117

13.1.6 SPAIN 121

13.1.7 SWITZERLAND 125

13.1.8 NETHERLANDS 129

13.1.9 BELGIUM 133

13.1.10 RUSSIA 137

13.1.11 TURKEY 141

13.1.12 REST OF EUROPE 145

14 EUROPE NASAL SPRAY MARKET, COMPANY LANDSCAPE 146

14.1 COMPANY SHARE ANALYSIS: EUROPE 146

15 COMPANY PROFILE 147

15.1 PFIZER INC. 147

15.1.1 COMPANY OVERVIEW 147

15.1.2 REVENUE ANALYSIS 147

15.1.3 COMPANY SHARE ANALYSIS 148

15.1.4 PRODUCT PORTFOLIO 149

15.1.5 RECENT DEVELOPMENTS 149

15.2 CIPLA INC. 150

15.2.1 COMPANY OVERVIEW 150

15.2.2 REVENUE ANALYSIS 150

15.2.3 COMPANY SHARE ANALYSIS 151

15.2.4 PRODUCT PORTFOLIO 151

15.2.5 RECENT DEVELOPMENTS 152

?

15.3 BAYER AG 153

15.3.1 COMPANY OVERVIEW 153

15.3.2 REVENUE ANALYSIS 153

15.3.3 COMPANY SHARE ANALYSIS 154

15.3.4 PRODUCT PORTFOLIO 154

15.3.5 RECENT DEVELOPMENTS 154

15.4 INNOVUS PHARMACEUTICALS, INC. 155

15.4.1 COMPANY OVERVIEW 155

15.4.2 REVENUE ANALYSIS 155

15.4.3 COMPANY SHARE ANALYSIS 156

15.4.4 PRODUCT PORTFOLIO 156

15.4.5 RECENT DEVELOPMENTS 156

15.5 GLAXOSMITHKLINE PLC. 157

15.5.1 COMPANY OVERVIEW 157

15.5.2 REVENUE ANALYSIS 157

15.5.3 PRODUCT PORTFOLIO 158

15.5.4 RECENT DEVELOPMENTS 158

15.6 ADAPT PHARMA, INC. 159

15.6.1 COMPANY OVERVIEW 159

15.6.2 GEOGRAPHIC PRESENCE 159

15.6.3 PRODUCT PORTFOLIO 160

15.6.4 RECENT DEVELOPMENTS 160

15.7 AISHWARYA GROUP 161

15.7.1 COMPANY OVERVIEW 161

15.7.2 PRODUCT PORTFOLIO 161

15.7.3 RECENT DEVELOPMENTS 161

15.8 ALLERGAN 162

15.8.1 COMPANY OVERVIEW 162

15.8.2 REVENUE ANALYSIS 162

15.8.3 PRODUCT PORTFOLIO 162

15.8.4 RECENT DEVELOPMENTS 163

15.9 ARIUS FORMULATIONS PVT LTD 164

15.9.1 COMPANY OVERVIEW 164

15.9.2 PRODUCT PORTFOLIO 164

15.9.3 RECENT DEVELOPMENTS 164

15.10 AURENA 165

15.10.1 COMPANY OVERVIEW 165

15.10.2 GEOGRAPHIC PRESENCE 165

15.10.3 PRODUCT PORTFOLIO 166

15.10.4 RECENT DEVELOPMENTS 166

15.11 CATALENT, INC 167

15.11.1 COMPANY OVERVIEW 167

15.11.2 REVENUE ANALYSIS 167

15.11.3 PRODUCT PORTFOLIO 168

15.11.4 RECENT DEVELOPMENTS 168

15.12 EGALET CORPORATION 169

15.12.1 COMPANY OVERVIEW 169

15.12.2 REVENUE ANALYSIS 169

15.12.3 PRODUCT PORTFOLIO 170

15.12.4 RECENT DEVELOPMENTS 170

15.13 J PHARMACEUTICALS 171

15.13.1 COMPANY OVERVIEW 171

15.13.2 PRODUCT PORTFOLIO 171

15.13.3 RECENT DEVELOPMENTS 171

15.14 LEEFORD HEALTHCARE LTD 172

15.14.1 COMPANY OVERVIEW 172

15.14.2 GEOGRAPHIC PRESENCE 172

15.14.3 PRODUCT PORTFOLIO 173

15.14.4 RECENT DEVELOPMENTS 173

15.15 MYLAN N.V. 174

15.15.1 REVENUE ANALYSIS 174

15.15.2 PRODUCT PORTFOLIO 175

15.15.3 RECENT DEVELOPMENTS 175

15.16 SANDOZ INTERNATIONAL GMBH 176

15.16.1 COMPANY OVERVIEW 176

15.16.2 GEOGRAPHIC PRESENCE 176

15.16.3 PRODUCT PORTFOLIO 177

15.16.4 RECENT DEVELOPMENTS 177

15.17 ST. RENATUS 178

15.17.1 COMPANY OVERVIEW 178

15.17.2 PRODUCT PORTFOLIO 178

15.17.3 RECENT DEVELOPMENTS 178

15.18 TEVA PHARMACEUTICAL INDUSTRIES LTD. 179

15.18.1 COMPANY OVERVIEW 179

15.18.2 REVENUE ANALYSIS 179

15.18.3 PRODUCT PORTFOLIO 180

15.18.4 RECENT DEVELOPMENTS 180

?

15.19 ULTRATECH INDIA LIMITED 181

15.19.1 COMPANY OVERVIEW 181

15.19.2 PRODUCT PORTFOLIO 181

15.19.3 RECENT DEVELOPMENTS 181

16 RELATED REPORTS 182

LIST OF FIGURES

FIGURE 1 EUROPE NASAL SPRAY MARKET: SEGMENTATION 19

FIGURE 2 EUROPE NASAL SPRAY MARKET: DATA TRIANGULATION 22

FIGURE 3 EUROPE NASAL SPRAY MARKET: RESEARCH SNAPSHOT 23

FIGURE 4 EUROPE NASAL SPRAY MARKET:BOTTOM UP APPROACH 24

FIGURE 5 EUROPE NASAL SPRAY MARKET:TOP DOWN APPROACH 24

FIGURE 6 EUROPENASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS 25

FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE NASAL SPRAY MARKET 28

FIGURE 8 EUROPE NASAL SPRAY MARKET: SEGMENTATION 36

FIGURE 9 IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY AND EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY ARE EXPECTED TO DRIVE THE MARKET FOR NASAL SPRAY IN THE FORECAST PERIOD 2018 TO 2025 37

FIGURE 10 DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NASAL SPRAY MARKET IN 2018 & 2025 38

FIGURE 11 EUROPE NASAL SPRAY MARKET: BY PRODUCT TYPE, 2017 40

FIGURE 12 EUROPE NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2017 48

FIGURE 13 EUROPE NASAL SPRAY MARKET: BY DOSAGE FORM, 2017 53

FIGURE 14 EUROPE NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2017 61

FIGURE 15 EUROPE NASAL SPRAY MARKET: BY APPLICATION, 2017 69

FIGURE 16 EUROPE NASAL SPRAY MARKET: BY PRESCRIPTION MODE, 2017 78

FIGURE 17 EUROPE NASAL SPRAY MARKET: BY END USER, 2017 84

FIGURE 18 EUROPE NASAL SPRAY MARKET SNAPSHOT (2017) 91

FIGURE 19 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2017) 92

FIGURE 20 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 92

FIGURE 21 EUROPE NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 93

FIGURE 22 EUROPE NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 93

FIGURE 23 EUROPE NASAL SPRAY MARKET: COMPANY SHARE 2017 (%) 140

LIST OF TABLES

TABLE 1 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016 -2025, (USD MILLION) 42

TABLE 2 EUROPE DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 43

TABLE 3 EUROPE SALT WATER SOLUTION/ SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 45

TABLE 4 EUROPE STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 46

TABLE 5 EUROPE OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 47

TABLE 6 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016 -2025, (USD MILLION) 50

TABLE 7 EUROPE PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 51

TABLE 8 EUROPE PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 52

TABLE 9 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM, 2016 -2025, (USD MILLION) 55

TABLE 10 EUROPE UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 57

TABLE 11 EUROPE BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 58

TABLE 12 EUROPE MULTI-DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 60

TABLE 13 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016 -2025, (USD MILLION) 63

TABLE 14 EUROPE ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 65

TABLE 15 EUROPE NASAL STEROID IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 66

TABLE 16 EUROPE MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 67

TABLE 17 EUROPE ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 68

TABLE 18 EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2016 -2025, (USD MILLION) 71

TABLE 19 EUROPE ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 73

TABLE 20 EUROPE NASAL CONGESTION RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 74

TABLE 21 EUROPE CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 75

TABLE 22 EUROPE VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 76

TABLE 23 EUROPE OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 77

TABLE 24 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016 -2025, (USD MILLION) 80

TABLE 25 EUROPE PRESCRIPTION BASED IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 81

TABLE 26 EUROPE OVER THE COUNTER BASED IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 83

TABLE 27 EUROPE NASAL SPRAY MARKET, BY END USER, 2016 -2025, (USD MILLION) 86

TABLE 28 EUROPE HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 87

TABLE 29 EUROPE CLINICS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 88

TABLE 30 EUROPE HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 89

TABLE 31 EUROPE COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 90

TABLE 32 EUROPEN ASAL SPRAY MARKET, BY COUNTRY, 2016-2025(USD MILLION) 95

TABLE 33 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 96

TABLE 34 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 96

TABLE 35 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 97

TABLE 36 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 97

TABLE 37 EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 98

TABLE 38 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 98

TABLE 39 EUROPE NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 99

TABLE 40 GERMANY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 100

TABLE 41 GERMANY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 100

TABLE 42 GERMANY NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 101

TABLE 43 GERMANY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 101

TABLE 44 GERMANY NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 102

TABLE 45 GERMANY NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 102

TABLE 46 GERMANY NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 103

TABLE 47 U.K. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 104

TABLE 48 U.K. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 104

TABLE 49 U.K. NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 105

TABLE 50 U.K. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 105

TABLE 51 U.K. NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 106

TABLE 52 U.K. NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 106

TABLE 53 U.K. NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 107

TABLE 54 FRANCE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 108

TABLE 55 FRANCE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 108

TABLE 56 FRANCE NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 109

TABLE 57 FRANCE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 109

TABLE 58 FRANCE NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 110

TABLE 59 FRANCE NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 110

TABLE 60 FRANCE NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 111

TABLE 61 ITALY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 112

TABLE 62 ITALY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 112

TABLE 63 ITALY NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 113

TABLE 64 ITALY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 113

TABLE 65 ITALY NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 114

TABLE 66 ITALY NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 114

TABLE 67 ITALY NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 115

TABLE 68 SPAIN NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 116

TABLE 69 SPAIN NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 116

TABLE 70 SPAIN NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 117

TABLE 71 SPAIN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 117

TABLE 72 SPAIN NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 118

TABLE 73 SPAIN NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 118

TABLE 74 SPAIN NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 119

TABLE 75 SWITZERLAND NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 120

TABLE 76 SWITZERLAND NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 120

TABLE 77 SWITZERLAND NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 121

TABLE 78 SWITZERLAND NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 121

TABLE 79 SWITZERLAND NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 122

TABLE 80 SWITZERLAND NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 122

TABLE 81 SWITZERLAND NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 123

TABLE 82 NETHERLANDS NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 124

TABLE 83 NETHERLANDS NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 124

TABLE 84 NETHERLANDS NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 125

TABLE 85 NETHERLANDS NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 125

TABLE 86 NETHERLANDS NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 126

TABLE 87 NETHERLANDS NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 126

TABLE 88 NETHERLANDS NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 127

TABLE 89 BELGIUM NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 128

TABLE 90 BELGIUM NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 128

TABLE 91 BELGIUM NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 129

TABLE 92 BELGIUM NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 129

TABLE 93 BELGIUM NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 130

TABLE 94 BELGIUM NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 130

TABLE 95 BELGIUM NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 131

TABLE 96 RUSSIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 132

TABLE 97 RUSSIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 132

TABLE 98 RUSSIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 133

TABLE 99 RUSSIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 133

TABLE 100 RUSSIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 134

TABLE 101 RUSSIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 134

TABLE 102 RUSSIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 135

TABLE 103 TURKEY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 136

TABLE 104 TURKEY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 136

TABLE 105 TURKEY NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 137

TABLE 106 TURKEY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 137

TABLE 107 TURKEY NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 138

TABLE 108 TURKEY NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 138

TABLE 109 TURKEY NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 139

TABLE 110 REST OF EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 140

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group

select a license
Single User License
USD 2500 INR 181375
Corporate User License
USD 3200 INR 232160

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com